Acronym/Abbreviation | Definition |
---|---|
18-OHB | 18-hydroxycorticosterone |
5-HT[3] | 5-hydroxytryptamine-3 |
6-TGN | 6-thioguanine |
AA | African American |
AAA | abdominal aortic aneurysm |
AACC | acute angle-closure crisis |
AAFP | American Academy of Family Physicians |
AAN | Academy of Neurology |
AAN | American Academy of Neurology |
AAP | abiraterone with prednisone or prednisolone |
AAP | American Academy of Pediatrics |
AAS | androgenic-anabolic steroid |
AASLD | American Association for the Study of Liver Diseases |
AATS | American Association for Thoracic Surgery |
ABC | abacavir |
ABCs | airway |
ABG | arterial blood gas |
ABI | Ankle brachial index |
ABI | ankle-brachial index |
ABLC | amphotericin B lipid complex |
ABPA | allergic bronchopulmonary aspergillosis |
ABR | auditory brainstem response |
ABRS | acute bacterial rhinosinusitis |
Abs | antibodies |
ABSSSI | acute bacterial skin and skin structure infections |
abx | antibiotics |
AC | allergic conjunctivitis |
AC | alternating current |
AC | anterior chamber |
ac | before meal |
AC | before meals |
ACC | adrenocortical carcinoma |
ACC | American College of Cardiology |
ACCF | American College of Cardiology Foundation |
ACD | Allergic contact dermatitis |
ACE | Angiotensin converting enzyme |
ACE | angiotensin-converting enzyme |
ACE | angiotensin-converting-enzyme |
ACE | asymptomatic cerebral embolism |
ACEI | Angiotensin-converting enzyme inhibitor |
ACHD | adult congenital heart disease |
AChR | acetylcholine receptor |
ACIP | Advisory Committee on Immunization Practices |
ACIP | Advisory Committee on Immunization Practices (CDC) |
ACLS | advanced cardiac life support |
ACLS | advanced cardiovascular life support |
ACOG | American Congress of Obstetricians and Gynecologists |
ACP | Advance Care Planning |
ACQ | Asthma Control Questionnaire |
ACR | albumin-to-creatinine ratio |
ACR | American College of Rheumatology |
ACS | acute coronary syndrome |
ACT | activated clotting time |
ACT | Assertive community treatment |
ACT | Asthma Control Test |
ACTH | adrenocorticotropic hormone |
AD | Alzheimer's Disease |
AD | Atopic dermatitis |
ADA | Adenosine deaminase |
ADA | American Diabetes Association |
ADA | Americans with Disabilities Act |
ADA | With Disabilities Act |
ADABG | blood glucose |
ADAG | A1C-derived average glucose |
ADHERE | Acute Decompensated Heart Failure National Registry |
ADI | acceptable daily intake |
ADL | activities of daily living |
ADM | adalimumab |
ADR | adverse drug reaction |
ADRDA | Alzheimer's Disease and Related Disorders Association |
ADT | Androgen Deprivation Therapy |
ADV | adefovir |
ADX | adrenalectomy |
AE | adverse event |
AE | angioedema |
AED | antiepileptic drug |
AED | automated external defibrillator |
AER | albumin excretion rate |
AERD | aspirin-exacerbated respiratory disease |
AETC | AIDS Education and Training Centers |
AF | atrial fibrillation |
AF/AFL/AT | atrial fibrillation/atrial flutter/atrial tachycardia |
AFB | Acid-fast bacilli |
AFP | alpha fetoprotein |
AFP | alphafetoprotein |
AGA | American Gastroenterological Association |
AGA | American Gastroenterological Association Institute |
AGEP | acute generalized exanthematous pusulosis |
AGL | acquired generalized lipodystrophy |
AH50 | Alternative pathway complement hemolysis 50% |
AHA | American College of Cardiology/American Heart Association |
AHA | American Heart Association |
AHCPR | Health Care Policy and Research |
AHI | apnea hypopnea index |
AHNMD | ssociated with lymphoproliferative disorders |
AHR | airway hyperresponsiveness |
AI | adequate intake |
AI | adrenal insufficiency |
AI | American Indian |
AI | aromatase inhibitor |
AIDP | Acute Inflammatory Demyelinating Polyneuropathy |
AIDS | acquired immune deficiency syndrome |
AIDS | Acquired Immunodeficiency Syndrome |
AIE | auto-injectable epinephrine |
AIMS | abnormal involuntary movement scale |
AIOD | aortoiliac occlusive disease |
AIP | aryl hydrocarbon receptor interacting protein |
AIT | allergen immunotherapy |
AIT | amiodarone-induced thyrotoxicosis |
AJC | active joint count |
AJCC | American Joint |
AJCC | American Joint Committee on Cancer |
AKI | acute kidney injury |
Al | aluminum |
ALA | alpha lipoic acid |
ALA | linolenic acid |
ALA | omega-3 linolenic acid |
ALF | Acute Liver Failure |
ALI | acute limb ischemia |
ALK | anaplastic lymphoma kinase |
ALKP | alkaline Phosphatase |
ALND | axillary lymph node dissection |
alpha-gal | galactose-a-1 |
ALPS | Autoimmune lymphoproliferative syndrome |
ALS | amyotrophic lateral sclerosis |
ALT | alanine aminotransferase |
ALT | alanine transaminase |
AM | before noon |
AMA-PCPI | American Medical Association-Physician Consortium for Performance Improvement |
AmB | amphotericin B |
AmBd | amphotericin B deoxycholate |
AMD | age-related macular degeneration |
AMH | anti-Muellerian hormone |
AMI | acute myocardial infarction |
AML | acute myeloid leukemia |
amox | amoxicillin |
AMP | adenosine monophosphate |
AN | Alaska Native |
ANA | anti-nuclear antibody |
ANA | antinuclear antibodies |
ANA | antinuclear antibody |
ANC | absolute neutrophil |
ANC | absolute neutrophil count |
ANCA | anti-neutrophil cytoplasmic antibodies |
ANNA-1 | Anti-Neuronal Nuclear Antibody 1 |
anti-HBc | antibody to hepatitis B total core antigen |
anti-HBc | hepatitis B core antibody |
anti-HBe | antibody to hepatitis B e antigen |
anti-HBs | antibodies to hepatitis B surface antigen |
anti-HBs | hepatitis B surface antibody |
anti-TNF | anti-tumor necrosis factor |
anti-VEGF | anti-vascular endothelial growth factor |
AOE | Acute otitis externa |
AOM | acute otitis media |
AOR | adjusted odds ratio |
AP | Acute pancreatitis |
AP | allergic proctocolitis |
APA | aldosterone-producing adenoma |
APECED | Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy |
APL | acquired partial lipodystrophy |
aPL | antiphospholipid antibodies |
APO | apolipoprotein |
ApoB | apolipoprotein B |
APOL1 | Apolipoprotein L1 |
APRS | Academic Performance Rating Scale |
APS | American Pain Society |
APST | autologous plasma skin test |
APT | atopy patch test |
aPTT | activated partial thromboplastic time |
aPTT | activated partial thromboplastin time |
AR | Allergic rhinitis |
AR | aortic regurgitation |
ARB | angiotensin II receptor blocker |
ARB | angiotensin receptor blocker |
ARB | angiotensin receptor blockers |
ARB | angiotensin-receptor blocker |
ARBs | angiotensin II type 1 receptor blockers |
ARDS | acute respiratory distress syndrome |
AREDS | Age-Related Eye Disease Study |
ARF | acute respiratory failure |
ARIC | Atherosclerosis Risk in Communities |
ARNI | angiotensin receptor neprilysin inhibitor |
ARNI | angiotensin receptor-neprilysin inhibitor |
ARR | aldosterone-to-renin ratio |
ARS | acute rhinosinusitis |
ART | antiretroviral therapy |
ARV | antiretroviral |
AS | active surveillance |
AS | ankylosing spondylitis |
AS | aortic stenosis |
ASA | aspirin |
ASA | Society of Anesthesiologists |
ASA | Society of Anethesiologists |
ASAM | American Society of Addiction Medicine |
ASAM | Society of Addiction Medicine |
ASAP | as soon as possible |
ASB | catheter-associated asymptomatic bacteriuria |
ASCO | American Society of Clinical Oncology |
ASCVD | atherosclerotic cardiovascular disease |
ASH | American Society of Hematology |
ASMA | anti-smooth muscle antibodies |
ASP | antibiotic stewardship program |
ASP | Average Sales Price |
ASPAN | American Society of PeriAnesthesia Nurses |
ASPECTS | Alberta Stroke Program Early Computed Tomography Score |
ASPs | antibiotic stewardship programs |
ASST | autologous serum skin test |
AST | Active surveillance testing |
AST | alanine serum transferase |
AST | aspartate aminotranserase |
AST | aspartate aminotransferase |
AT | Ataxia-telangiectasia |
AT | Atrial tachycardia |
ATA | American Thyroid Association |
ATA | Association Largest tinnitus |
ATC | anaplastic thyroid carcinoma |
ATG | anti-thymocyte globulin |
ATP | Adult Treatment Panel |
ATP | antitachycardia pacing |
ATS | American Thoracic Society |
ATV | atazanavir |
ATV/c | cobicistat-boosted atazanavir |
ATV/r | ritonavir-boosted atazanavir |
AUA | America Urological Association |
AUA | American Urologic Association |
AUC | area under the curve |
AUC | area under the time vs. serum concentration curve |
AUD | Alcohol Use Disorder |
AUS/FLUS | atypia of undetermined significance/follicular lesion of undetermined significance |
AV | arteriovenous |
AV | atrioventricular |
AVA | aortic valve area |
AVAi | aortic valve area indexed to body surface area |
AVNRT | atrioventricular nodal reentrant tachycardia |
AVR | (open) aortic valve replacement |
AVR | aortic valve replacement |
AVRT | atrioventricular reentrant tachycardia |
AVS | adrenal venous sampling |
AZA | azathioprene |
AZA | azathioprine |
b-HB | b-hydroxybutyrate |
b2 | beta agonist |
BAH | bilateral adrenal hyperplasia |
BAL | and bronchoalveolar lavage |
BAL | bronchoalveolar lavage |
BAS | Bile Acid Sequestrants |
BCG | Bacillus Calmette-Guerin |
BCLC | Barcelona Clinic Liver Cancer |
BCS | breast-conserving surgery |
BCVA | best corrected visual acuity |
BDD | Body Dysmorphic Disorder |
BDNF | brain-derived neurotrophic factor |
BG | blood glucose |
BIC | bictegravir |
BiCROS | bilateral contralateral routing of signal |
bid | twice a day |
bid | twice daily |
bid | two times a day |
BIPAP | bilevel positive airway pressure |
BiVAD | biventricular assist device |
BLT | bow and lean test |
BM | bone marrow |
BMA | bone-modifying agents |
BMAH | bilateral macronodular adrenal hyperplasia |
BMD | bone mineral density |
BMI | Body mass index |
BMI | body mass index (kg/m2) |
BMS | bare-metal stent |
BMT | bone marrow transplant |
BNP | B-type natriuretic peptide |
BNP | brain natriuretic peptide |
BP | blood pressure |
bpm | beats per minute |
BPPV | Benign Paroxysmal Position Vertigo |
BPPV | benign paroxysmal positional vertigo |
BPRS | Brief Psychiatric Rating Scale |
Bq | Becquerel |
BR | Response Biochemical |
BS | blood sugar |
BSA | body surface area |
BSFS | Bristol Stool Form Scale |
BTE | Behind the Ear |
BTK | Bruton tyrosine kinase |
BTT | bridge to transplantation |
BTxB | botulinum toxin type B |
BU | Bethesda Unit |
BUN | blood urea nitrogen |
Bx | biopsy |
BZA | bazedoxifene |
C | cholesterol |
C | cornea |
C&S | culture and sensitivity |
C282Y | Cys282Tyr mutation |
Ca | calcium |
CA | community-associated |
CA-MRSA | community-acquired MRSA[ |
CA-MRSA | community-associated methicillin-resistant Staphylococcus aureus |
CA-MRSA | community-associated MRSA[ |
CA-UTI | catheter-associated urinary tract infection |
CABG | coronary artery bypass graft |
CABG | coronary artery bypass grafting |
CAC | coronary artery calcium |
CaCO3 | Calcium carbonate |
CAD | coronary artery disease |
CAH | Congenital adrenal hyperplasia |
CAM | complementary and alternative medicine |
CAN | cardiovascular autonomic neuropathy |
CAP | American Society of Clinical Oncology and College of American Pathologists |
CAP | community-acquired pneumonia |
CAPD | chronic ambulatory peritoneal dialysis |
CAPS | Cryopyrin-associated periodic syndrome |
CARD | Caspase recruitment domain |
cART | combination antiretroviral therapy |
CAS | carotid angioplasty and stenting |
CAS | carotid artery stenting |
CASP10 | Caspase 10 |
CASP8 | Caspase 8 |
CASPR | California Acute Stroke Pilot Registry |
CB | ciliary body with ciliary processes |
CBA | colistin-base activity |
CBC | complete blood cell count |
CBC | complete blood count |
CBG | corticosteroid binding globulin |
CBT | Cognitive behavior therapy |
CBT | cognitive behavioral therapy |
CBZ | carbamazepine |
CC | chronic constipation |
CCA | common carotid artery |
CCB | calcium channel blocker |
CCH | Cell hyperplasia |
CCO | Cancer Care Ontario |
CCP | Cyclic citrullinated peptide |
CCP | cyclic citrullinated peptides |
CCPA | Chronic Cavitary Pulmonary Aspergillosis |
CCR5 | C chemokine receptor type 5 |
CCR5 | CC chemokine receptor 5 |
CCS | Canadian Cardiovascular Society |
CCT | captopril challenge test |
CCTA | cardiac computed tomography angiography |
CCTA | coronary CT angiography |
CCTA | coronary/cardiac computed tomography angiography |
CCW | Chronic Condition Warehouse |
CD | Crohn's disease |
CD | Cushing's disease |
CD20i | CD20 inhibitor |
CD4 | CD4 T lymphocyte |
CD40L | CD40 ligand |
CD45 | protein tyrosine phosphatase receptor type C |
CDAI | Clinical Disease Activity Index |
CDC | Center for Disease Control |
CDC | Centers for Disease Control and Prevention |
CDI | Clostridium difficile infection |
cDMARDs | conventional disease modifying anti-rheumatic drugs |
CE | carcinoembryonic antigen |
CEA | After carotid endarterectomy |
CEA | carcinoembryonic antigen |
CEA | carotid endarterectomy |
CEAP | Clinical Class |
CEE | conjugated equine estrogens |
CEP17 | centromeric probe for chromosome 17 |
CETP | cholesteryl ester transfer protein |
cf | continuous flow |
CF | cystic fibrosis |
CFA | common femoral artery |
CFHR | Complement factor H-related protein |
CFRD | cystic fibrosis-related diabetes |
cfu | colony-forming units |
CFU/g | colony-forming units per gram of tissue |
CGD | chronic granulomatous disease |
CGL | congenital generalized lipodystrophy |
CGM | continuous glucose monitoring |
CH | Cluster headache |
CH50 | Classical pathway complement hemolysis 50% |
CH50 | total hemolytic complement |
CHA2DS2-VASc | Congestive heart failure |
CHAARTED | Chemohormonal Androgen Ablation Randomized Trial |
CHADS2 | Congestive heart failure |
CHARGE | Coloboma |
CHARM | Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity |
CHD | congenital heart disease |
CHD | coronary heart disease |
ChEI | cholinesterase inhibitor |
CHEST | American College of Chest Physicians |
CHEST | The American College of Chest Physicians |
CHF | congestive heart failure |
CHH | Cartilage-hair hypoplasia |
CHL | conductive hearing loss |
CHO | carbohydrate |
CHS | Cardiovascular Health Study |
CHS | Chediak-Higashi syndrome |
CI | confidence interval |
Ci | curie |
CIC | in the Canal |
CID | Combined immunodeficiency |
CIDT | culture independent diagnostic testing |
CIED | cardiac implantable electronic device |
CIED | cardiovascular implantable electronic device |
CII | continuous [40]*insulin infusion |
CIMT | carotid intima-media thickness |
CIN | cervical intraepithelial dysplasia |
CINCA | Chronic infantile neurocutaneous articular |
CIS | carcinoma in situ |
CISNE | Clinical Index of Stable Febrile Neutropenia |
CIU | chronic idiopathic urticaria |
CK | creatine kinase |
CK-MB | creatine kinase myocardial isoenzyme |
CK-MB | creatine kinase-MB[ |
CKD | chronic kidney disease |
CKD-EPI | Chronic Kidney Disease Epidemiology Collaboration |
Cl | chloride |
CL | Cutaneous Leishmaniasis |
CLA | cutaneous lichen amyloidosis |
CLABSI | central line-associated blood stream infections |
ClCr | creatinine clearance |
CLEC7A | C-type lectin domain family 7 |
CLI | critical limb ischemia |
CLIA | Clinical Laboratory Improvement Amendments |
CLIA/CAP | Clinical Laboratory Improvement Amendments/College of American Pathologists |
CLT | cuff leak test |
CM | carbimazole |
CM | coccidioidal meningitis |
CMAP | compound muscle action_content potentials |
CMCC | Chronic mucocutaneous candidiasis |
CME | cystoid macular edema |
CMP | comprehensive metabolic panel |
CMR | cardiac magnetic resonance |
CMS | U.S. Center for Medicare & Medicaid Services |
CMV | cytomegalovirus |
CND | central neck dissection |
CNI | calcineurin inhibitors |
CNS | central nervous system |
CNV | choroidal neovascularization |
CO | cardiac output |
CO | conscientious objection |
CO | conscientious objections |
CO-HCFA | community-onset healthcare facility-associated |
CO2 | carbon dioxide |
cobi | cobicistat |
COBRA | Combinatietherapie Bij Reumatoide Artritis |
COE | Class of Evidence |
COLEC11 | Collectin subfamily member 11 |
COME | chronic otitis media with effusion |
COPD | chronic obstructive pulmonary disease |
COR | Class of Recommendation |
COR | Classification of Recommendation |
CORONA | Controlled Rosuvastatin Multinational Trial in Heart Failure |
COWS | Clinical Opioid Withdrawal Scale |
COX | cyclooxygenase |
COX-2 | cyclooxygenase 2 |
COX-2 | cyclooxygenase-2 |
COX-2 inhibitor | cyclooxygenase-2 inhibitor |
CP | contact precautions |
CPA | cyproterone acetate |
CPAP | continuous positive airway pressure |
CPG | clinical practice guideline |
CPIS | Clinical Pulmonary Infection Score |
CPIS | Modified Clinical Pulmonary Infection Score |
CPK | creatine phosphokinase |
CPK | creatine phosphokinsase |
CPO | Cardiac Power Output |
CPP | cerebral perfusion pressure |
CPR | cardiopulmonary resuscitation |
CPT | current procedural terminology |
CR | complete response |
CR | controlled release |
Cr | creatinine |
CRAB | hypercalcemia |
CRC | colorectal cancer |
CrCl | creatinine clearance |
CRE | carbapenem resistant Enterobacteriaceae |
CRMO | chronic recurrent multifocal osteomyelitis |
CROS | contralateral routing of signal |
CRP | C-reactive protein |
CRP | canalith repositioning procedure |
CRPC | castration-resistant prostate cancer |
CRS | chronic rhinosinusitis |
CRT | Cardiac Resynchronization Therapy |
CRT | cognitive remediation therapy |
CRT-D | cardiac resynchronization therapy defibrillator |
CRT-D | cardiac resynchronization therapy with defibrillator |
CRT-D | cardiac resynchronization therapy with implantable cardioverter defibrillator |
CRT-P | cardiac resynchronization therapy-pacemaker |
CRT-Pacemaker | cardiac resynchronization therapy pacemaker |
CS | corticosteroids |
CS | Cushing's syndrome |
CSA | cyclosporin A |
CSA | cyclosporine |
CSF | cerebrospinal fluid |
CSF | colony- stimulating factor |
CSF | colony-stimulating factor |
CSF | Signs Cerebrospinal Fluid |
CSFs | Colony stimulating factors |
CSII | continuous subcutaneous insulin infusion |
CSME | clinically significant macular edema |
CT | cardiothoracic |
CT | Computed tomographic |
CT | computed tomography |
CT | computerized tomography |
CTA | computed tomography angiography |
CTI | cavotricuspid isthmus |
CTLA-4 | cytotoxic T lymphocyte- associated protein 4 |
CTLA-4 | cytotoxic T-cell lymphocyte-4 |
Ctn | Calcitonin |
CTPA | computed tomographic pulmonary angiography |
CTT | Cholesterol Treatment Trialists Collaboration eGFR |
CU | chronic urticaria |
CUA | chronic urticaria and angioedema |
CV | cardiovascular |
CVA | cerebrovascular accident |
CVC | central venous catheters |
CVD | cardiovascular disease |
CVID | common variable immunodeficiency |
CVP | central venous pressure |
CVT | Cerebral Venous Thrombosis |
CVVHD | continuous venovenous hemodialysis |
CW | continuous wave |
CWAA | cell-wall active agent |
CXR | chest radiograph |
CXR | chest X-ray |
CyA | cyclosporine |
CYC | cyclophosphamide |
CYP | cytochrome P |
CYP | cytochrome P450 |
CYP3A4 | cytochrome P450 isoenzyme 3A4 |
CZP | certolizumab |
d | day |
D-CK-MB | delta-creatine kinase-MB[ |
D/C | discontinue |
D10W | 10% dextrose solution |
D25W | 25% dextrose solution |
D2B | door-to-balloon (device) |
d4T | stavudine |
D5W | 5% dextrose in water |
DA | dopamine agonist |
DAA | direct-acting antiviral |
DAPT | dual antiplatelet therapy |
DAPT | dual-antiplatelet therapy |
DAS | Disease Activity Score |
DASH | Dietary Approaches to Stop Hypertension |
DAT | direct agglutination test |
DBP | diastolic blood pressure |
DBS | Deep brain stimulation |
DCCT | Diabetes Control and Complications Trial |
DCDD | circulatory determination of death |
DCDD | donation after circulatory determination of death |
DCIS | Ductal carcinoma in situ |
DCM | dilated cardiomyopathy |
DD | dyssynergic defecation |
DD | dysthmic disorder |
DD | dysthymic disorder |
DDD | defined daily dose |
ddI | didanosine |
DDI | drug-drug interactions |
DDMVAC | dose-dense methotrexate |
DES | drug-eluting stent |
DES | drug-eluting stent(s) |
DF | dominant excitation frequency |
DFA | direct fluorescent antibody |
DFI | diabetic foot infection |
DFO | diabetic foot osteomyelitis |
DFS | disease free survival |
DFS | disease-free survival |
DFU | diabetic foot ulcer |
DGS | DiGeorge syndrome |
DHA | docosahexaenoic acid |
DHEA | dehydroepiandrosterone |
DHEA-S | dehydroepiandrosterone sulfate |
DHEAS | dehydroepiandrosterone sulfate |
DHHS | US Department of Health and Human Services |
DHPs | dihydropyridines |
DHR | Dihydrorhodamine 123 |
DHT | dihydrotestosterone |
DI | diabetes insipidus |
DIC | disseminated intravascular coagulation |
DIDO | door-in-door-out |
DIHS | drug-induced hypersensitivity syndrome |
DILE | drug-induced lupus erythematosus |
DILI | Drug Induced Liver Injury |
DIP | distal interphalangeal joint |
DIRA | Deficiency of IL-1 receptor antagonist |
DITRA | Deficiency of IL-36 receptor antagonist |
div | divided |
DKA | diabetes ketoacidosis |
DKA | diabetic ketoacidosis |
DKC | Dyskeratosis congenita |
DKD | Diabetic Kidney Disease |
DLCO | diffusing capacity for carbon monoxide |
DLCO | diffusing capacity of the lung for carbon monoxide |
DLCO | transfer factor of the lung for carbon monoxide |
DLCO2 | diffusion capacity for carbon dioxide |
DM | dextromethorphan |
DM | diabetes mellitus |
DMARD | Disease Modifying Antirheumatic Drug (includes hydroxychloroquine |
DMARD | disease-modifying antirheumatic drug |
DMARD | disease-modifying antirheumatic drugs |
DMARD | disease-modifying antirrheumatic drug |
DMARDs | disease modifying anti-rheumatic drugs |
DMARDs | disease-modifying antirheumatic drugs |
DME | diabetic macular edema |
DME | durable medical equipment |
dMMR | mismatch repair-deficient |
DNA | Deoxyribonucleic Acid |
DNR | do not resuscitate |
DOCK8 | Dedicator of cytokinesis 8 |
DOD | Department of Defense |
DOT | days of therapy |
DOT | directly observed therapy |
DP | pressure gradient |
DPI | daily powder inhaler |
DPI | dry powder inhaler |
DPN | diabetic peripheral neuropathy |
DPNP | diabetic peripheral neuropathic pain |
DPP-4 | dipeptidyl peptidase 4 |
DPP-4 | dipeptyl peptidase 4 |
DPP-4-i | DPP-4 inhibitor |
DPUA | delayed pressure urticaria/angioedema |
DRC | direct renin concentration |
DRE | digital rectal examination |
DRESS | drug rash with eosinophilia and systemic symptoms |
DRESS | drug reaction with eosinophilia and systemic symptoms |
DRESS | drug-related rash with eosinophilia and systemic symptoms |
DRI | Dietary Reference Intakes |
DRS | Diabetic Retinopathy Study |
DRV | darunavir |
DRV/c | cobicistat-boosted darunavir |
DRV/r | ritonavir-boosted darunavir |
DS | duodenal switch |
DSE | dobutamine stress echocardiogram |
DSE | dobutamine stress echocardiography |
DSEK | Descemet stripping endothelial keratoplasty |
DSM | Diagnostic and Statistical Manual of Mental Disorders |
DSM-5 | Diagnostic and Statistical Manual of Mental Disorders |
DSME | Diabetes Self Management Education |
DSME | diabetes self-management education |
DSMS | diabetes self-management support |
DSP | drospirenone |
DT | diphtheria and tetanus toxoids (pediatric formulation) |
DT | diphtheria-tetanus vaccine |
DTaP | diphtheria and tetanus toxoids and acellular pertussis (pediatric formulation) |
DTaP | diphtheria-tetanus-acellular pertussis vaccine |
DTC | differentiated thyroid cancer |
DTC | differentiated thyroid carcinoma |
DTG | dolutegravir |
DTPI | deep-tissue pressure injury |
DUS | duplex ultrasound |
DVT | deep vein thrombosis |
DVT | deep veinthrombosis |
DVT | deep venous thrombosis |
DW | dosing weight |
Dx | diagnosis |
DXA | dual x-ray absorptiometry |
DXA | dual-energy X-ray absorptiometry |
DXA | dualenergy X-ray absorptiometry |
DxWBS | diagnostic whole body scan |
E | estrogen |
E2 | 17-B [24]*estradiol |
E2 | estradiol |
EA | early antigen |
eAG | estimated average glucose |
EAS | ectopic ACTH secretion |
EAS | European Atherosclerosis Society |
EASL | European Association for the Study of the Liver |
EAU | European Association of Urology |
EBRT | external beam radiotherapy |
EBSLN | external branch of the superior laryngeal nerve |
EBV | Epstein-Barr virus |
ECCE | extracapsular cataract extraction |
ECG | electrocardiogram |
ECG | electrocardiogram/electrocardiographic |
ECG | electrocardiograph |
ECG | electrocardiographic |
ECMO | extracorporeal membrane oxygenation |
ECOG | Eastern Cooperative Oncology Group |
ECT | ecarin clotting time |
ECT | electroconvulsive therapy |
ED | emergency department |
ED | erectile dysfunction |
EDS | excessive daytime sleepiness |
EDV | end-diastolic velocity |
EE | erosive esophagitis |
EE | ethinyl estradiol |
EEG | electroencephalogram |
EF | ejection fraction |
EFFECT | Enhanced Feedback for Effective Cardiac Treatment |
EFV | efavirenz |
EG | Eosinophilic gastroenteritis |
EGD | esophagogastric distension |
EGD | esophagogastroduodenoscopy |
EGFR | epidermal growth factor receptor |
eGFR | estimated glomerular filtration rate |
EGM | electrogram |
EIA | enzyme immunoassay |
EIA | enzyme immunoassays |
EIA | exercise-induced anaphylaxis |
EIAn | exercise-induced anaphylaxis |
EIB | exercise-induced bronchoconstriction |
EKG | electrocardiogram |
EKG | electrocardiograph |
ELISA | enzyme-linked immunosorbent assay |
EM | Erythema multiforme |
EMA | European Medicines Agency |
EMB | ethambutol |
EMG | electromyogram |
EMG | electromyography |
EMI | electromagnetic interference |
EML | Essential Medicines List |
EMLA | lidocaine and prilocaine topical anesthetic |
EMS | emergency medical services |
EMS | emergency medical/transport services |
EN | enteral nutrition |
ENoG | electroneuronography |
ENT | ear |
EoE | eosinophilic esophagitis |
EP | electrophysiological |
EP | expert panel |
EPA | eicosapentaenoic acid |
EPA | Environmental Protection Agency |
EPA and DHA | long-chain omega-3 fatty acids |
EPCAM | epithelial cell adhesion molecule |
EPD | extended pleurectomy/decortication |
EPP | either extrapleural pneumonectomy |
EPP | extrapleural pneumonectomy |
EPS | extracellular polymeric substance |
EPS | extrapyramidal symptoms |
EPT | estrogen plus progestogen therapy |
ER | emergency room |
ER | estrogen receptor |
ER | extended release |
ERC | Evidence Review Committee |
ERCP | endoscopic retrograde cholangiopancreatography |
ERI | elective replacement indicator |
ERI | elective replacement interval |
ERO | effective regurgitant orifice |
ERS | European Respiratory Society |
ES | Endocrine Society |
ES | evidence statement |
ESBL | extended-spectrum b-lactamase |
ESBL | extended-spectrum beta-lactamase |
ESC | European Society of Cardiology |
ESCAPE | Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness |
ESM | ethosuximide |
ESR | erythrocyte sedimentation rate |
ESRD | end-stage renal disease |
ET | endotracheal tube |
ET | estrogen therapy |
ETDRS | Early Treatment Diabetic Retinopathy Study |
ETE | extrathyroidal extension |
ETEC | enterotoxigenic E. coli |
EtG | ethyl glucuronide |
ETN | etanercept |
EtOH | ethyl alcohol or ethanol |
ETR | etravirine |
EtS | ethyl sulfate |
ETT | exercise treadmill test |
ETV | entecavir |
EULAR | European League Against Rheumatism |
EUS | endoscopic ultrasonography |
EV | Epidermodysplasia verruciformis |
EVAR | endovascular aneurysm repair |
EVG | elvitegravir |
EVG/c | cobicistat-boosted elvitegravir |
EVH | eucapnic voluntary hyperpnea |
EVT | endovascular therapy |
FA | FOOD ALLERGY |
FAAN | Food Allergy and Anaphylaxis Network (now Food Allergy |
FAB | functional abdominal bloating |
FACBC | 18F-flucicovine |
FAD | functional abdominal distention |
FAQ | functional activities questionnaire |
FBD | functional bowel disorder |
FC | Functional Constipation |
FCAS | Familial cold autoinflammatory syndrome |
FDA | Federal Drug Administration |
FDA | Food and Drug Administration |
FDA | U.S. Food and Drug Administration |
FDA | US Food and Drug Administration |
FDEIA | food-dependent exercise-induced anaphylaxis |
FDG | 18F-Fluorodeoxyglucose |
FDr | functional diarrhea |
Fe | iron |
FEIBA | Factor Eight Inhibitor Bypassing Activity |
FeNO | exhaled nitric oxide fraction |
FEUA | fractional excretion of uric acid |
FEV1 | forced expiratory volume in 1 sec |
FEV1 | forced expiratory volume in 1 second |
FEV1 | forced expiratory volume in one second |
FEV1/FVC | ratio of forced expiratory volume in 1 second to forced vital capacity |
FEV[1] | forced expiratory volume in 1 second |
FE[phos] | fractional excretion of phosphate |
FFP | fresh frozen plasma |
FFR | fractional flow reserve |
FH | familial hypercholesterolemia |
FH-I | -II |
FHA | functional hypothalamic amenorrhea |
FHL | Familial hemophagocytic lymphohistiocytosis |
FHx | family history |
FIQ | Fibromyalgia Impact Questionnaire |
FISH | fluorescence in situ hybridization |
FISH | fluorescent in situ hybridization |
FIT | fecal immunochemical test |
FLACS | femtosecond laser-assisted cataract surgery |
FLAIR | fluid attenuated inversion recovery |
FLP | fasting lipid panel |
FMC | first medical contact |
FMF | familial Mediterranean fever |
FMP | final menstrual period |
FMT | fecal microbiota transplantation |
FN | false negative |
FN | febrile neutropenia |
FN/SFN | follicular neoplasm/suspicious for follicular neoplasm |
FNA | Fine needle aspiration |
FNA | fine-needle aspiration |
FOXP3 | Forkhead box protein 3 |
FP | false positive |
FPG | fasting plasma glucose |
FPIES | food protein-induced enterocolitis syndrome |
FPLD | familial partial lipodystrophy |
FPOD | femoropopliteal occlusive disease |
FPV | fosamprenavir |
FSGS | focal segmental glomerulosclerosis |
FSH | follicle stimulating hormone |
FSH | follicle-stimulating hormone |
FST | fludrocortisone suppression test |
FT | free testosterone |
FT4 | (plasma) free thyroxine |
fT4 | free thyroxine |
FTC | emtricitabine |
FTC | Follicular thyroid cancer |
FTC | follicular thyroid carcinoma |
FTMH | full-thickness macular hole |
FU | follow-up |
FUT | furosemide upright test |
FVC | forced vital capacity |
Fx's | bone fractures |
g | gram |
G-CSF | granulocyte colony-stimulating factor |
G1 | Grade 1 |
G2 | Grade 2 |
G3 | Grade 3 |
G4 | Grade 4 |
G6PD | glucose-6-phosphate dehydrogenase |
G6PDH | Glucose-6-phosphate dehydrogenase |
GA | geriatric assessment |
GABA | gamma-amino-butyric acid |
GABHS | group A b-hemolytic streptococcus |
GAD | glutamate decarboxylase |
GAS | Group A b-hemolytic streptococcus |
GBP | gabapentin |
GBS | Guillain-Barre Syndrome |
GC | glucocorticoid |
GC | glucocorticoids |
GCSF | granulocyte colony-stimulating factor |
GCT | Glucose challenge test |
GD | Gender dysphoria |
GD/GI | gender dysphoria/gender incongruence |
GDH | glutamate dehydrogenase |
GDM | Gestational diabetes mellitus |
GDMT | guideline determined medical therapy |
GDMT | guideline-directed management and therapy |
GDMT | guideline-directed medical therapy |
GDS | Geriatric Depression Scale |
GE | gastroesophageal |
GERD | gastro-esophageal reflux disease |
GERD | gastroesophageal reflux disease |
GFR | glomerular filtration rate |
GFV | graft flow velocity |
GGT | g-glutamyl transferase |
GH | Growth hormone |
GHBP | growth hormone binding protein |
GHD | Growth Hormone Deficiency |
GHIS | growth hormone insensitivity syndrome |
GHR | growth hormone receptor |
GHRH | growth hormone-releasing hormone |
GI | gastrointestinal |
GI | Gender incongruence |
GI | glycemic index |
GINA | Global Initiative for Asthma |
GIOP | glucocorticoid-induced osteoporosis |
GIP | gastric inhibitory polypeptide |
GIP | glucose-dependent insulinotropic peptide |
GIP | glucose-dependent insulinotropic polypeptide |
GLP-1 | glucagon-like peptide 1 |
GLP-1 | glucagon-like peptide-1 |
GLP-1-RA | GLP-1 receptor agonist |
GLP-1-RA | glucagon-like peptide-1 receptor agonist |
GLT | glucose load test |
GM | galactomannan |
GM-CSF | granulocyte macrophage colony-stimulating factor |
GM-CSF | granulocyte-macrophage colony-stimulating factor |
gm/day | grams per day |
gm/kg | grams per kilogram |
GN | glomerulonephritis |
GNR | Gram-negative rod |
GnRH | gonadotropin-releasing hormone |
GOL | golimumab |
GP | glycoprotein |
GPC | Giant Papillary Conjunctivitis |
GPC | Gram-positive cocci |
GPI | glycoprotein IIb/IIIa inhibitor |
GPI | glycosyl-phosphatidylinositol |
GPR | good practice recommendation |
GRA | glucocorticoid remediable aldosteronism |
GRACE | Global Registry of Acute Coronary Events |
GRADE | Grading of Recommendations Assessment |
GRAS | generally recognized as safe |
GS | gastric sleeve |
GS | Griscelli syndrome |
GSM | genitourinary syndrome of menopause |
GU | genitourinary |
GVHD | graft versus host diseases |
GVHD | graft-versus-host disease |
GVHD | graft-vs-host disease |
GWG | gestational weight gain |
Gy | Gray |
H | high |
h | hour |
h | hour(s) |
h | hours |
H&P | history and physical |
H2 | histamine-2 |
H2RA | histamine2-receptor blockers |
H63D | His63Asp mutation |
HA | hypothalamic amenorrhea |
HA-MRSA | healthcare-associated MRSA[ |
HA-MRSA | hospital-acquired methicillin-resistant Staphylococcus aureus |
HAART | highly active antiretroviral therapy |
HAD | HIV-associated dementia |
HAE | hereditary angioedema |
HAMP | hepcidin |
HAP | hospital-acquired pneumonia |
HAQ | Health Assessment Questionnaire |
HAQ-DI | Health Assessment Questionnaire Disability Index |
HAS-BLED | Hypertension |
HAT | and hearingassistive technology |
HAT | hearing-assistive technology |
HAV | hepatitis A virus |
Hb | hemoglobin |
HbA1C | hemoglobin A1C |
HbA1c | hemoglobin A1c (glycohemoglobin) |
HBcAb | antibody to hepatitis B total core antigen |
HBcAb | hepatitis B core antibody |
HBeAg | hepatitis B e antigen |
HBO | hyperbaric oxygen |
HBOT | hyperbaric oxygen therapy |
HBsAb | hepatitis B surface antibody |
HBsAg | hepatitis B surface antigen |
HBV | hepatitis B virus |
HC | hormonal contraceptive |
HCC | and hepatocellular carcinoma |
HCC | hepatocellular carcinoma |
HCC | of hepatocellular carcinoma |
hCG | human chorionic gonadotropin |
HCM | hypertrophic cardiomyopathy |
HCO3 | bicarbonate |
HCP | health care personnel |
HCP | health care practitioner |
HCP | health care professional |
HCP | healthcare providers |
HCQ | hydroxychloroquine |
Hct | hematocrit |
HCTZ | hydrochlorthiazide |
HCV | hepatitis C virus |
HD | hemodialysis |
HD | High Dose |
HD | Hirschsprung's Disease |
HDL | high-density lipoprotein |
HDL | high-density lipoprotein cholesterol |
HDL-C | high density lipoprotein cholesterol |
HDL-C | high density lipoprotein-cholesterol |
HDL-C | high-density lipoprotein cholesterol |
HDV | hepatitis D virus |
HELLP | Hemolysis |
HepA | hepatitis A vaccine |
HEPA | high-efficiency particulate air |
HepB | hepatitis B vaccine |
HER2 | human epidermal growth factor receptor 2 |
HER2+ | human epidermal growth factor receptor 2-positive |
HES | hydroxyethyl starch |
HES | hypereosinophilic syndrome |
HF | heart failure |
HFA | Heart Failure Association |
HFA | hydrofluoroalkane |
HFmrEF | heart failure with mid-range ejection fraction |
HFpEF | heart failure with preserved ejection fraction |
HFrEF | heart failure with reduced ejection fraction |
Hgb | hemoglobin |
HgbA1c | glycated hemoglobin |
HgbA1C | hemoglobin A1C |
HGVS | Human Genome Variation Society |
HH | Hereditary hemochromatosis |
HHF | Hearing Health Foundation |
HHV6 | human herpesvirus 6 |
Hib | Haemophilus influenzae type B |
Hib | Haemophilus influenzae type b conjugate vaccine |
HIC | hepatic iron concentration |
HIDS | Hyper-IgD syndrome |
HIES | Hyper-IgE syndrome |
HIM | Hyper-IgM syndrome |
HIV | human immunodeficiency virus |
HIV-1 | HIV type 1 |
HIV/AIDS | human immunodeficiency virus/acquired immunodeficiency syndrome |
HIVAN | HIV-associated nephropathy |
HIVMA | HIV Medicine Association |
HJV | hemojuvelin |
HLA | human leukocyte antigen |
HLH | Hemophagocytic lymphohistiocytosis |
HNSCC | squamous cell carcinoma |
HO-CDI | healthcare facility-onset C. difficile infection |
HOB | head of bed |
HP | Helicobacter pylori |
HPA | hypothalamic-pituitary-adrenal |
hpf | high-power field |
HPLC | high-performance liquid chromatography |
HPO | hypothalamic-pituitary-ovarian |
HPS | Hermansky-Pudlak syndrome |
HPTH | hyperparathyroidism |
HPV | Human papilloma virus |
HPV | human papillomavirus |
HPV2 | bivalent human papillomavirus vaccine |
HPV4 | quadrivalent human papillomavirus vaccine |
HQ | hydroxychloroquine |
HR | hazard ratio |
HR | heart rate |
HR+ | hormone receptor-positive |
HRCT | high-resolution computed tomography |
HRQOL | health-related quality of life |
hrs | hours |
HRT | hormone replacement therapy |
HRV | heart rate variability |
hs-CRP | high-sensitivity C-reactive protein |
HSCT | hematopioetic stem cell transplant |
HSCT | Hematopoietic stem cell therapy |
HSCT | hematopoietic stem cell transplant |
HSCT | hematopoietic stem cell transplantation |
HSCT | hematopoietic stem cell transplantation HIV |
HSD | hydroxysteroid dehydrogenase |
HSE | herpes simplex encephalitis |
HSR | hypersensitivity reaction |
HSV | Herpes simplex virus |
HSV | herpes simplex viruses |
HSV | Herpes simplexvirus |
HT | hormone therapy |
HT | hypertension |
HTLV | human T-cell lymphotropic virus |
HTN | hypertension |
HU | Hounsfield units |
HUS | Hemolytic uremic syndrome |
HUVS | Hypocomplementemic urticarial vasculitis syndrome |
hydral-nitrates | hydralazine and isosorbide dinitrate |
hyper-IgD | hyper-IgD syndrome with periodic fever |
HZ | Herpes zoster |
I | iris |
I & D | incision and drainage |
I-PRESERVE | Irbesartan in Heart Failure With Preserved Heart Function |
IA | inflammatory arthritis |
IA | intra articular |
IA | Invasive Aspergillosis |
IABP | intra-aortic balloon counterpulsation |
IABP | intra-aortic balloon pump |
IACUC | Institutional Animal Care and Use Committee |
IADPSG | International Association of Diabetes and Pregnancy Study Groups |
IAH | idiopathic adrenal hyperplasia |
IBCG | International Bladder Cancer Group |
IBD | Inflammatory bowel disease |
IBIS | International Breast Intervention Study |
IBS | Irritable bowel syndrome |
IBS-C | irritable bowel syndrome with constipation |
IBS-C | irritable bowel syndrome with constipation-predominant symptoms |
IBS-D | irritable bowel syndrome with diarrhea |
IBS-D | irritable bowel syndrome with diarrhea-predominant symptoms |
IBS-M | irritable bowel syndrome with constipation and diarrhea |
IBS-M | irritable bowel syndrome with mixed pattern |
IBS-U | irritable bowel syndrome unclassified |
IBW | ideal body weight |
IC | Informed Consent |
IC | Intermittent Claudication |
ICA | internal carotid artery |
ICA | Isolated congenital asplenia |
ICD | implantable cardioverter defibrillator |
ICD | implantable cardioverter defibrillators |
ICD | implantable cardioverter-defibrillator |
ICD | International Statistical Classification of Diseases and Related Health Problems |
ICD-9 | International Classification of Diseases - Ninth Revision |
ICD4L | Idiopathic CD4 lymphopenia |
ICE | iridocorneal endothelial |
ICF | Immunodeficiency |
ICG | indocyanine green |
ICH | intracranial hemorrhage |
ICH | intracranial hypertension |
ICP | intracranial pressure |
ICPi | immune checkpoint inhibitor |
ICS | inhaled corticosteroid |
ICS | inhaled corticosteroids |
ICU | intensive care unit |
ICU | intensive care units |
ICUD | International Consultation on Urological Diseases |
ID | infectious disease |
IDCF | immunodiffusion complement-fixing (anticoccidioidal antibodies) |
IDEAL | Incremental Decrease through Aggressive Lipid Lowering study |
IDF | International Diabetes Federation |
IDSA | Infectious Diseases Society of America |
IDV | integrase strand transfer inhibitor |
IE | infective endocarditis |
IFA | immunofluorescence antigen |
IFA | indirect fluorescent antibody |
IFG | impaired fasting glucose |
IFIS | intraoperative floppy iris syndrome |
IFN | interferon |
IFN-a | interferon-alpha |
IFN-g | interferon g |
IFN-g | Interferon gamma |
IFNGR | IFN-g receptor |
Ig | immune globulin |
IG | Interpretive Guidance |
IgA | immunoglobulin A |
IGC | International Guidelines Center |
IgE | immunoglobulin E |
IGF | insulin-like growth factor |
IGF | insulinlike growth factor |
IGF-1 | insulin-like growth factor-1 |
IgG | immunogloblulin G |
IgG | immunoglobulin G |
IGGSD | IgG subclass deficiency |
IgM | immunoglobulin M |
IGRA | interferon-g release assay |
IGRA | Interferon-gamma release assay |
IGT | impaired glucose tolerance |
IHA | idiopathic hyperaldosteronism |
IHC | immunohistochemical |
IHC | immunohistochemistry |
IHD | Ischemic Heart Disease |
III | of MRSA infections |
IIV | inactivated influenza vaccine |
IIV | Influenza virus vaccine |
IKBA | Inhibitor of kB a chain |
IKBKG | Inhibitor of kB kinase g chain |
IL | interleukin |
IL | intralesional |
IL-1 | interleukin-1 |
IL12/23i | interleukin 12/23 inhibitor |
IL17i | interleukin 17 inhibitor |
IL17RA | IL-17 receptor a chain gene |
IL2RG | Interleukin 2 receptor subunit gamma gene |
IL6i | interleukin 6 inhibitor |
ILD | interstitial lung disease |
ILM | internal limiting membrane |
ILR | implantable loop recorder |
IM | intramuscular |
IM | intramuscularly |
IMA | inferior mesenteric artery |
IMAGe | intrauterine growth restriction |
IMRT | intensity-modulated radiation therapy |
IMT | Implantable Miniature Telescope(TM) |
INA | intranasal antihistamines |
IND | Investigational New Drug |
INF | infliximab |
information | which may include data supplements |
inh | inhalation |
INH | inhibitor |
INH | isoniazid |
inhibitors | angiotensin-converting enzyme inhibitors |
INR | international normalised ratio |
INR | international normalized ratio |
INS | intranasal steroids |
INSTI | integrase strand transfer inhibitor |
INTERMACS | Interagency Registry for Mechanically Assisted Circulatory Support |
IOL | intraocular lens |
IOM | Institute of Medicine |
IOP | intraocular pressure |
IOP | of intraocular pressure |
IPA | Invasive Pulmonary Aspergillosis |
IPC | Infection Prevention and Control |
IPEX | Immunodeficiency |
IPF | Idiopathic pulmonary fibrosis |
IPL | intense pulsed light |
IPPB | intermittent positive pressure breathing |
IPSS | inferior petrosal sinus sampling |
IPSS | International Prostate Symptom Score |
iPTH | intact parathyroid hormone |
IPV | inactivated polio vaccine |
IPV | inactivated poliovirus vaccine |
IQR | interquartile range |
IR | immediate release |
IR | inadequate response |
irAE | immune-related adverse event |
IRAK | IL-1 receptor-associated kinase |
IRIS | immune reconstitution inflammatory syndrome |
IS | ischemic stroke |
ISH | in situ hybridization |
ISN/RPS | International Society of Nephrology/Renal Pathology Society |
ISR | in-stent restenosis |
ISS | Idiopathic Short Stature |
ISSNHL | idiopathic sudden sensorineural hearing loss |
IST | Inappropriate sinus tachycardia |
IT | information technology |
IT | intra-tympanic |
ITC | In the Canal |
ITC | iridotrabecular contact |
ITCH | Itchy E3 ubiquitin protein ligase |
ITK | IL-2-inducible T-cell kinase |
ITP | idiopathic thrombocytopenic purpura |
IU | international unit |
IU | international units |
IU/L | international units per liter |
IUD | intrauterine device |
IV | intraenous |
IV | intravenous |
IVC | inferior vena cava |
IVF | in vitro fertilization |
IVIG | intravenous immune globulin |
IVIG | Intravenous immunoglobulin |
IVs | intravenous lines |
IWGDF | International Working Group on the Diabetic Foot |
JIA | juvenile idiopathic arthritis |
JIA | juvenille idiopathic arthritis |
JVP | jugular venous pressure |
K | potassium |
K+ | potassium |
KAS | Key Action Statement |
KAS | Key Action Statements |
KAS | key action_content statement |
KCC | Kings College Criteria |
kg | kilogram |
KPC | Klebsiella pneumoniae carbapenemase |
KPC | Klebsiella pneumoniae carbapenemase-producing bacteria |
KRAS | Kirsten rat sarcoma viral oncogene homolog |
KS | Klinefelter syndrome |
L | lens |
L | low |
LA | left atrial |
LA | left atrial/left atrium |
LA | left atrium |
LA | left atrium/atrial |
LA-A&B | Los Angeles Classification grades A & B (none |
LAA | left atrial appendage |
LABA | long acting b2 agonist |
LABA | long-acting b-agonist |
LABA | long-acting b[2]-agonist |
LABA | long-acting b[2]-agonists |
LAD | left anterior descending |
LAD | left anterior descending coronary artery |
LAD | Leukocyte adhesion deficiency |
LAGB | laparoscopic adjustable gastric banding |
LAIV | Live attenuated influenza vaccine |
LAM | lamivudine |
LAMA | long-acting muscarinic antagonist |
LAR | long-acting release |
LASIK | laser-assisted in situ keratomileusis |
LATITUDE | A Study of Abiraterone Acetate Plus Low-Dose Prednisone Plus Androgen Deprivation Therapy (ADT) Versus ADT Alone in Newly Diagnosed Participants With High-Risk |
LBBB | left bundle branch block |
LBBB | left bundle-branch block |
LBM | lean body mass |
LBP | Low back pain |
LC | lens capsule |
LD | Lactate dehydrogenase |
LD | loading dose |
LDH | lactate dehydrogenase |
LDL | low-density lipoprotein |
LDL-C | low-density lipoprotein cholesterol |
LdT | telbivudine |
LE | life expectancy |
LE | lower extremity |
LEF | leflunomide |
LEMS | Lambert-Eaton Myasthenic Syndrome |
LFAmB | lipid formulations of AmB |
LFT | liver function test |
LFT | liver function tests |
LFTs | liver function tests |
LGA | large-for-gestational-age/macrosomia |
LH | luteinizing hormone |
LH | lutenizing hormone |
LIG4 | DNA ligase IV[ |
LIMA | left internal mammary artery |
LLN | lower limit of normal |
LLRs | large local reactions |
LMWH | low molecular weight heparin |
LMWH | low-molecular-weight heparin |
LN | Lupus Nephritis |
LN | lymph node |
LN | lymph nodes |
LND | lymph node dissection |
LNorg | levonorgestrel |
LOD | limit of detection |
LOE | Level of Evidence |
Lp(a) | lipoprotein(a) |
LPI | laser peripheral iridotomy |
LPR | laryngopharyngeal reflux |
LPR4 | lipoprotein related 4 |
LPV | lopinavir |
LPV/r | ritonavir-boosted lopinavir |
LT3 | liothyronine |
LT4 | levothyroxine |
LTB4 | leukotriene B4 |
LTBI | latent tuberculosis infection |
LTC | long-term care |
LTG | lamotrigine |
LTR | life-threatening reaction |
LTRA | leukotriene receptor antagonist |
LUTS | lower urinary tract symptoms |
LV | left ventricle |
LV | left ventricle/left ventricular |
LV | left ventricular |
LV | leftventricular |
LVAD | left ventricular assist device |
LVEDD | left ventricular end-diastolic dimension |
LVEF | left ventricle ejection fraction |
LVEF | left ventricular ejection fraction |
LVESD | left ventricular end-systolic dimension |
LVH | left ventricular hypertrophy |
LVIDd | left ventricular end-diastolic internal dimension |
LVOT | left ventricular outflow tract |
LVSD | left ventricular systolic dysfunction |
LVT | levetiracetam |
LYG | life years gained |
M | metastatic MTC[ |
M | moderate |
MACE | major adverse cardiac event |
MACE | major adverse cardiac events |
MAHA | microangiopathic hemolytic anemia |
MAM | 6-monoacetylmorphine |
MAO | monoamine oxidase |
MAOI | monoamine oxidase inhibitor |
MAP | mean arterial pressure |
MAPK | mitogenactivated protein kinase |
MAS | macrophage activation syndrome |
MASCC | Multinational Association for Supportive Care |
MASCC | Multinational Association for Supportive Care in Cancer |
MAT | Multifocal atrial tachycardia |
Max | maximum |
MBC | metastatic breast cancer |
MBCL | methylbenzethonium chloride |
MBL | mannan-binding lectin |
MC2R | melanocortin 2 receptor gene |
MCAS | Mast Cell Activating Syndrome |
MCM | major congenital malformation |
MCM4 | Minichromosome maintenance complex component 4 |
MCM4 | minichromosome maintenance-deficient 4 |
mCRPC | metastatic castration-resistant prostate cancer |
MCS | mast cell stabilizing agent |
MCS | Mechanical circulatory support |
MCT | Medium chain triglyceride |
MCV | mean corpuscular volume |
MCV4 | quadrivalent meningococcal conjugate vaccine |
MD | maintenance dose |
MD global | physician global assessment |
MDCT | multidetector computed tomography scan |
MDD | major depressive disorder |
MDI | metered-dose inhaler |
MDI | multiple daily injections |
MDI | multiple-dose insulin |
MDR | multi-drug resistant |
MDR | multidrug resistant |
MDR-E | multidrug-resistant Enterobacteriaceae |
MDRO | multidrug-resistant organism |
MDS | acute myeloid leukemia/myelodysplastic syndrome |
MDS | minimum data set |
MDS | myelodysplastic syndrome |
MDS | myelodysplastic syndromes |
MedDRA | Medical Dictionary for Regulatory Activities |
MEDPED | Make Early Diagnosis to Prevent Early Death |
MEE | middle ear effusion |
MEE | most often effusion |
MELD | Model for End-Stage Liver Disease |
MEN | multiple endocrine neoplasia |
MEN1 | multiple endocrine neoplasia-1 |
MET | metabolic equivalent |
METs | metabolic equivalent (1 MET = 3.5 mL/kg/min oxygen uptake) |
MetS | metabolic syndrome |
MeV | million electron volts |
Mg | magnesium |
mg | milligram |
mg | milligram(s) |
mg | milligrams |
MG | Myasthenia Gravis |
mg/dL | milligrams per deciliter |
mg/kg | milligrams per kilogram |
MGD | meibomian gland dysfunction |
MGFA | Myasthenia Gravis Foundation of America |
MHC | Major histocompatibility complex |
MHD | monohydroxy derivative |
MHP | mental health professional |
MHT | menopausal hormone therapy |
MI | myoardial infarction |
MI | myocardial infarction |
MI | myocardial infarction MNT |
MIA | multiple intestinal atresia |
MIC | Minimum Inhibitory Concentration |
MICA | Myocardial Infarction and Cardiac Arrest |
MIE | mechanical insufflation/exsufflation |
min | minute |
min | minute(s) |
min(s) | minute(s) |
MIP | maximal inspiratory pressure |
MIPS | Merit-based Incentive Payment System |
mL | milliliter |
ML | Mucosal Leishmaniasis |
MLST | multiple sleep latency test |
mm | millimeter |
MMA | methyl-malonic acid |
MMAS | Mast Cell Activating Syndrome |
MMAS | monoclonal mast cell activating syndrome |
MMF | mycophenolate mofetil |
MMI | methimazole |
MMPs | matrix metalloproteinases |
MMR | measles |
MMRV | measles |
MMRV | quadrivalent MMR-varicella vaccine |
MMSE | Mini-Mental State Exam |
MMSE | Mini-Mental State Examination |
MNT | medical nutrition therapy |
MNTT | multiple daily injections |
mo | month |
mo | month(s) |
MODY | maturity-onset diabetes of the young |
MOM | milk of magnesia |
mos | months |
MP-NAAT | multiple pathogen nucleic acid amplification tests |
MPA | medroxyprogesterone acetate |
MPA | mycophenolic acid |
mPAP | mean pulmonary artery pressure |
MPFS | Medicare Physician Fee Schedule |
MPGN | membranoproliferative glomerulonephritis |
MPHD | multiple pituitary hormone deficiencies |
MPI | myocardial perfusion imaging |
MPL | monophospholipid |
MPM | malignant pleural mesothelioma |
MPS | Macular Photocoagulation Study |
MPS | Myofascial Pain Syndrome |
MPSV4 | quadrivalent meningococcal polysaccharide vaccine |
MR | magnetic resonance |
MR | mineralocorticoid receptor |
MR | mitral regurgitation |
MR(I) | magnetic resonance (imaging) |
MRA | magnetic resonance angiography |
MRA | mineralocorticoid receptor antagonist |
MRA | MR agonist |
MRAP | melanocortin receptor accessory protein |
mRCC | metastatic RCC[ |
MRE | magnetic resonance elastography |
MRI | imaging |
MRI | magnetic resonance imaging |
MRO | Medical Review Officer |
MRSA | community-acquired methicillin-resistant Staphylococcus aureus |
MRSA | Methicillin resistant Staphylococcus aureus |
MRSA | methicillin-resistant S. aureus |
MRSA | methicillin-resistant Staphylococcus aureus |
ms | millisecond |
ms | milliseconds |
MS | mitral stenosis |
MS | Multiple Sclerosis |
MSI-H | Microsatellite instability-high |
MSM | men who have sex with men |
MSM | sex with men |
MSMD | Mendelian susceptibility to mycobacterial disease |
MSMD | susceptibility to mycobacterial disease |
MSSA | methicillin-sensitive S. aureus |
MSSA | methicillin-sensitive Staphylococcus aureus |
MSSA | methicillin-susceptible Staphylococcus aureus |
MST1 | Macrophage stimulating 1 |
Mtb | Mycobacterium tuberculosis |
MTC | medullary thyroid cancer |
MTC | medullary thyroid carcinoma |
MTD | Mycobacteria Tuberculosis Direct |
MTHFD1 | Methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1 |
MTOR | mammalian target of rapamycin |
MTP | microsomal triglyceride transfer protein. |
MTX | methotrexate |
MU | million units |
MUFA | monounsaturated fatty acid |
MUGA | multi-gated acquisition |
MuSK | muscle specific kinase |
MV | megavolt |
mV | millivolts |
MV | mitral valve |
MVA | mitral valve area |
MVC | maraviroc |
MVI | multivitamins |
MVK | Mevalonate kinase |
MVR | mitral valve replacement |
MWS | Muckle-Wells syndrome |
MyD88 | Myeloid differentiation primary response 88 |
N | node |
N/A | not applicable |
N/A | not available |
NA | not available |
NA | nucleoside analogues |
NA | nucleoside/nucleotide analogue |
Na | sodium |
NAAT | nucleic acid amplification test |
NAB | nanoparticle albumin-bound |
NAC | N-acetyl cysteine |
NAC | N-acetylcysteine |
NACT | neoadjuvant chemotherapy |
NAEPP | National Asthma Education and Prevention Program |
NAFLD | non-alcoholic fatty liver disease |
NAFLD | nonalcoholic fatty liver disease |
NAM | National Academy of Medicine |
NaP | sodium phosphate |
NARMS | National Antimicrobial Resistance Monitoring system |
NASH | nonalcoholic steatohepatitis |
NB | No Benefit |
NBS | Nijmegen breakage syndrome |
NCCAH | for nonclassical congenital adrenal hyperplasia |
NCCAH | nonclassical congenital adrenal hyperplasia |
NCCN | National Comprehensive Cancer Network |
NCEP | National Cholesterol Education Program |
NCGP | National Glycohemoglobin Standardization Program |
NCI | National Cancer Institute |
NCS | nerve conduction study |
Nd:YAG | neodymium yttrium-aluminium-garnet |
NDDG | National Diabetes Data Group |
NED | no evidence of disease |
NEMO | Nuclear factor kB essential modulator |
NERD | nonerosive reflux disease |
NERDS | Nonhealing |
Neta | norethindrone acetate or norethisterone acetate |
NF-kB | Nuclear factor kB |
NFV | nelfinavir |
NGSP | National Glycohemoglobin Standardization Program |
NHLBI | National Heart |
NHSN | National Healthcare Safety Network |
NHW | non-Hibic white |
NIAID | National Institute of Allergy and Infectious Diseases |
NICU | neonatal intensive care unit |
NIDA | National Institute on Drug Abuse |
NIF | negative inspiratory force |
NIH | National Health Institute |
NIH | National Institutes of Health |
NIHSS | National Institutes of Health Stroke Scale |
NINCDS | National Institute of Neurological and Communication Disorders and Stroke |
NIV | non-invasive ventilation |
NIV | noninvasive ventilation |
NK | Natural killer |
NK[1] | neurokinin 1 |
NL | Normal |
NLA | National Lipid Association |
nm | nonmutated |
NMIBC | non-muscle invasive bladder cancer |
NMS | neuroleptic malignant syndrome |
NNRTI | non-nucleoside reverse transcriptase inhibitor |
NNRTI | nonnucleoside reverse transcriptase inhibitor |
NNS | Nakajo-Nishimura syndrome |
NNS | nonnutritive sweeteners |
NNT | nicotinamide nucleotide transhydrogenase |
NNT | number needed to treat |
NOAC | novel oral anticoagulant |
NOAC(s) | novel oral anticoagulants |
NOD2 | Nucleotide-binding oligomerization domain-containing protein 2 |
NOMID | neonatal-onset multisystem inflammatory disease |
NOMID | Neonatal-onset multisystem inflammatory disorder |
Non-HDL-C | non-high-density lipoprotein cholesterol |
NOSE | Nasal Obstruction Symptom Evaluation |
Nothing | Found |
NP-59 | iodomethyl-19-norcholesterol |
NPDR | nonproliferative diabetic retinopathy |
NPH | Neutral protamine Hagedorn |
NPO | nothing by mouth |
NPO | nothing by mouth (per os) |
NPUAP | National Pressure Ulcer Advisory Panel |
NPV | negative predictive value |
NPWT | negative pressure wound therapy |
NQF | National Quality Forum |
NQMI | non-Q-wave myocardial infarction |
NR | not reported |
NRTI | nucleoside reverse transcriptase inhibitor |
ns | nonsignificant |
NS | normal saline |
NSA | Negative Symptoms Assessment |
NSAID | non-steroidal anti-inflammatory drug |
NSAID | nonsteroidal anti-inflammatory drug |
NSAID | nonsteroidal antiinflammatory drug |
NSAIDs | Non-Steroidal Anti-Inflammatory Drugs |
NSAIDs | nonsteroidal anti-inflammatory drugs |
NSAIDs | nonsteroidal antiinflammatory drugs |
NSCLC | non-small cell lung cancer |
NSCLC | non-small-cell lung cancer |
NSQIP | National Surgical Quality Improvement Program |
NSTE-ACS | non-ST-elevation acute coronary syndrome |
NSTEMI | non-ST-elevation myocardial infarction |
NSTI | necrotizing soft tissue infections |
NT-pro-BNP | N-terminal pro-brain natriuretic peptide |
NT-proBNP | N-terminal pro-B-type natriuretic peptide |
NT-proBNP | N-terminal pro-brain natriuretic peptide |
NT-proBNP | N-terminal proBNP[ |
NTC | Normal transit constipation |
NTCTCSG | National Thyroid Cancer Treatment Cooperative Study Group |
NTG | nitroglycerin |
NVE | native valve endocarditis |
NVI | neovascularization of the iris |
NVO | Native Vertebral Osteomyelitis |
NVP | nevirapine |
NWCL | New World cutaneous leishmaniasis |
NYHA | New York Heart Association |
OA | oral antihistamines |
OA | osteoarthritis |
OAG | open angle glaucoma |
OAG | open-angle glaucoma |
OAR | Open aneurysm repair |
OAS | Oral allergy syndrome |
OBD | Opioid bowel dysfunction |
OBOT | Office-Based Opioid Treatment |
OC | Ocular Cysticercosis |
OC | oral contraceptive |
OC | oral contraceptives |
OCP | oral contraceptive pill |
OCS | oral corticosteroids |
OCT | Optical coherence tomography |
ODT | oral dissolving tablet |
OGTT | oral glucose tolerance test |
OGTT | oral glucose tolerance test (1.75 g/kg |
OHA | oral hypoglycemic agent |
OHP | 17-hydroxyprogesterone |
OHSS | ovarian hyperstimulation syndrome |
OHTS | Ocular Hypertension Treatment Study |
OI | opportunistic infection |
OIC | opioid-induced constipation |
OLT | orthotopic liver transplantation |
OME | otitis media with effusion |
OMMP | Ocular Mucous Membrane Pemphigoid |
ONH | optic nerve head |
ONJ | osteonecrosis of the jaw |
OOWS | Objective Opioid Withdrawal Scale |
OP | osteoporosis |
OPO | organ procurement organization |
OPTIMIZE-HF | Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure |
OPV | oral polio vaccine |
OPV | Oral poliovirus vaccine |
ORS | oral rehydration solution |
ORT | Opioid Risk Tool |
OS | Omenn syndrome |
OS | ovarian function suppression |
OS | overall survival |
OSA | obstructive sleep apnea |
OSR | open surgical reduction |
OSR | open surgical repair |
OTC | over the counter |
OTC | over-the-counter |
OTP | Opioid Treatment Program |
OTP | Opioid Treatment Programs |
OTS | Opioid Treatment Services |
OUD | Opioid use disorder |
OVD | ophthalmic viscosurgical device |
OXC | oxcarbazepine |
p | pressure |
p | pulsatile |
P/D | pleurectomy/decortication |
P4 | progesterone |
P53 | cellular tumor antigen p53 or tumor protein p53 |
PA | post-acute |
PA | posteroanterior |
PA | Primary aldosteronism |
PA | pulmonary artery |
PAC | plasma aldosterone concentration |
PAC | premature atrial contraction |
PAC | primary angle closure |
PACU | pediatric acute care unit |
PAD | Peripheral Arterial Disease |
PAD | peripheral artery disease |
PAH | pulmonary artery hypertension |
PAI | Primary adrenal insufficiency |
PAL | Physical Activity Levels |
PAM | primary acquired melanosis |
PANSS | Positive and Negative Symptom Scale |
PANSS | Positive and Negative Symptoms Scale |
PAP | positive airway pressure |
PAP | Pulmonary alveolar proteinosis |
PAPA | pyogenic arthritis |
PAR | perennial allergic rhinitis |
PAS | Patient Activity Scale |
PAS | peripheral anterior synechiae |
PASP | pulmonary artery systolic pressure |
PAWP | pulmonary artery wedge pressure |
PAX8 | paired box protein Pax 8 or paired box 8 |
PB | peripheral blood |
PB | phenobarbital |
PBPC | peripheral-blood progenitor cell |
PC | Palliative Care |
PC | platelet concentrate |
PC | posterior chamber |
PCCCL | pediatric congenital cardiac catheterization laboratory |
PCEF | peak cough expiratory flow |
PCI | percutaneous coronary intervention |
PCO | polycystic ovaries |
PCO | Posterior Capsular Opacification |
PCOS | polycystic ovarian syndrome |
PCOS | polycystic ovary syndrome |
PCP | phencyclidine |
PCP | Pneumocystis jirovecii pneumonia |
PCP | pneumocystis pneumonia |
PCR | polymerase chain reaction |
PCR | protein-to-creatinine ratio |
PCS | primary cytoreductive surgery |
PCV | pneumococcal conjugate vaccine |
PCV13 | 13-valent pneumococcal conjugate vaccine |
PCV13 | pneumococcal conjugate vaccine 13 |
PCV7 | 7-valent PCV[ |
PCWP | pulmonary capillary wedge pressure |
PD | peritoneal dialysis |
PD | programmed death |
PD-1 | programmed death 1 |
PD-L1 | programmed death ligand 1 |
PDE4i | phosphodiesterase 4 inhibitor [[23]*apremilast] |
PDGF | platelet-derived growth factor |
PDMP | Prescription Drug Monitoring Program |
PDMP | prescription drug monitoring programs |
PDR | proliferative diabetic retinopathy |
PDT | photodynamic therapy |
PE | pulmonary embolism |
PEA | pulseless electric activity |
PECT-CT | single-photon emission tomography/computed tomography |
PEDIS | perfusion |
PEEP | positive end-expiratory pressure |
PEF | peak expiratory flow rate measurement |
PEG | percutaneous endoscopic gastrostomy |
PEG | polyethylene glycol |
PEG-ELS | polyethylene glycol-electrolyte lavage solution |
pegIFN-a | pegylated interferon-alpha |
PEI | percutaneous ethanol injection |
PER | protein excretion rate |
PES | paclitaxel-eluting stent |
PES | Pediatric Endocrine Society |
PES | post-extubation stridor |
PET | fludeoxyglucose |
PET | fludeoxyglucose-positron emission tomography |
PET | Positron emission tomography |
PEX | plasma exchange |
PFAPA | periodic fever |
PFAPA | Periodic fever with aphthous stomatitis |
PFAPA | periodic fevers with aphthous stomatitis |
PFO | patent foramen ovale |
PFS | progression-free survial |
PFS | progression-free survival |
PG | plasma glucose |
PGBH | post-gastric bypass hypoglycemia |
PGM3 | Phosphoglycerate mutase 3 |
PgR | progesterone receptor |
PH | paradoxical hypertrichosis |
PH | Pulmonary hypertension |
PHA | Phytohemagglutinin |
PHA-2 | pseudohypoaldosteronism type 2 (familial hypertension and hyperkalemia with normal glomerular filtration rate) |
PHEO | pheochromocytoma |
PHN | post-herpetic neuralgia |
PHN | postherpetic neuralgia |
PHP | Physician Health Program |
PHT | phenytoin |
PHTN | pulmonary hypertension |
PI | Prescribing Information |
PI | protease inhibitor |
PI/r | ritonavir-boosted protease inhibitor |
PICU | pediatric intensive care unit |
PIDD | primary immunodeficiency disease |
PIDS | Pediatric Infectious Diseases Society |
PIGFD | primary IGF-I deficiency |
PIP | proximal interphalangeal joint |
PJI | Prosthetic joint infection |
PJRT | permanent form of junctional reciprocating tachycardia |
PK | pharmacokinetically |
PLAID | Phospholipase Cg2-associated antibody deficiency and immune dysregulation |
PLATO | PLATelet Inhibition and Patient Outcomes study |
PLWH | persons living with HIV |
PM | pacemaker |
PM | portable monitors |
PMBC | percutaneous mitral balloon commissurotomy |
PMNs | polymorphonuclear cells |
PMP | postmenopausal |
PMS2 | Postmeiotic segregation increased 2 |
PMT | pacemaker-mediated tachycardia |
PN | parenteral nutrition |
PN | Partial nephrectomy |
PNH | paroxusmal nocturnal hemoglobinuria |
PNS | penicillin-nonsusceptible |
PNU | protein nitrogen unit |
PO | by mouth |
PO | oral |
PO | orally |
PO | per os |
POAG | primary open-angle glaucoma |
POC | point of care |
POC | point-of-care |
POC | Practicing Ophthalmologists Curriculum |
POCT | point of care testing |
POI | primary ovarian insufficiency |
POMC | proopiomelanocortin |
PORT | Patient Outcomes Research Team |
PPAR | peroxisome proliferator-activated receptor |
PPBG | post-prandial blood glucose |
PPD | purified protein derivative |
PPE | palmoplantar erythrodysaesthesia |
PPG | Postprandial glucose |
PPI | proton pump inhibitor |
PPI | proton pump inhibitors |
PPI | proton-pump inhibitor |
PPM | personal protective measures |
PPSV | pneumococcal polysaccharide vaccine |
PPSV23 | pneumococcal polysaccharide vaccine 23 |
PPT | Postpartum Thyroiditis |
PPV | positive predictive value |
PPV23 | 23-valent pneumococcal polysaccharide vaccine |
PR | per rectum |
PR | progesterone receptor |
PR | pulmonic regurgitation |
PRA | plasma renin activity |
PRBC | packed red blood cells |
pred | predicted |
PRES | posterior reversible encephalopathy syndrome |
prescription | URI |
PRL | prolactin |
PRM | primidone |
prn | as needed |
PRN | asneeded |
PRN | individualized discontinuous treatment regimen |
ProACTIVE | Prospective Pioglitazone Clinical Trial in Macrovascular Events |
PROM | predicted risk of mortality |
PS | pain score |
PS | performance status |
PSA | Prostate specific antigen |
PSA | prostate-specific antigen |
PSA | prostatic specific antigen |
PsA | psoriatic arthritis |
PSC | posterior subcapsular cataract |
PSG | polysomnography |
PSI | PORT Severity Index |
PSIA | protein synthesis-inhibiting agent |
PSMA | prostate-specific membrane antigen |
PSMB8 | Proteasome catalytic subunit b type 8 |
PSTPIP1 | Proline-serine-threonine phosphatase interacting protein 1 |
PSV | peak systolic velocity |
PSVT | paroxysmal supraventricular tachycardia |
PT | partial thromboplastin time |
PT | Physical therapy |
PT | prothrombin time |
pt(s) | patient(s) |
PTA | percutaneous transluminal angioplasty |
PTB | probe to bone |
PTC | papillary thyroid cancer |
PTC | papillary thyroid carcinoma |
PTCA | percutaneous transluminal coronary angioplasty |
PTEN | gene: phosphatase and tensin homolog |
PTEN | phosphatase and tensin homolog |
PTINR | Prothrombin Time and International Normalized Ratio |
PTMC | papillary thyroid microcarcinoma |
PTT | partial thromboplastin time |
PTU | propylthiouracil |
PUA | plasma concentration of uric acid |
PUFA | polyunsaturated fatty acid |
PUPPS | pruritic urticarial papules and plaques of pregnancy |
PV | pulmonary vein |
PVAD | percutaneous ventricular assist device |
PVC | premature ventricular contraction |
PVD | peripheral vascular disease |
PVE | prosthetic valve endocarditis |
PVR | pulmonary vascular resistance |
PVR | pulse volume recording |
PZA | pyrazinamide |
P[creat] | plasma concentration of creatinine |
P[phos] | plasma concentration of phosphorus |
q | every |
Q | quinidine |
q day | daily |
q12h | every 12 hours |
q3-4d | every 3 to 4 days |
q3d | every 3 days |
QA | quality assurance |
qd | daily |
qd | once daily |
qhs | at bedtime |
qhs | bedtime |
qhs | every night at bedtime |
QI | Quality Improvement |
qid | 4 times a day |
QID | four times a day |
qid | four times daily |
QOL | Quality of Life |
QOL | quality of live |
QTc | corrected QT interval |
QTc | corrected QT interval (on ECG) |
QwMI | Q-wave myocardial infarction |
R/O | rule out |
RA | rheumatoid arthritis |
RA | right atrial/right atrium |
RA | right atrium |
RA | right atrium/atrial |
RAAS | renin-angiotensin-aldosterone system |
RADAI | Rheumatoid Arthritis Disease Activity Index |
RADAR | of Disease Activity in Rheumatology |
RADT | rapid antigen detection test |
RAG | Recombination-activating gene |
RAI | radioactive iodine |
RAI | radioiodine |
RAIU | radioactive iodine uptake |
RAL | raltegravir |
RAM | RAND/UCLA Appropriateness Method |
RAP | right atrial pressure |
RAS | rat sarcoma viral oncogene homolog |
RAS | Ryden Aggression Scale |
RBC | red blood cell |
RBCK1 | RanBP-type and C3HC4-type zinc finger containing 1 |
RBCs | red blood cells |
RCC | renal cell cancer |
RCC | renal cell carcinoma |
RCM | radiocontrast material |
RCM | radiocontrast media |
RCRI | Revised Cardiac Risk Index |
RCT | randomized |
RCT | randomized clinical trial |
RCT | randomized controlled trial |
RCT | randomized controlled trial. |
RCT | randomized controlled trials |
RCTs | randomized |
RCTs | randomized controlled trials |
RD | registered dietician |
RDA | recommended daily allowance |
RDI | respiratory disturbance index |
RDN | registered dietitian nutritionist |
RECIST | Response Evaluation Criteria In Solid Tumors |
Recs | recommendations |
RET | REarranged during Transfection |
RF | radio frequency |
RF | regurgitant fraction |
RF | rheumatoid factor |
RF | risk factor |
RFA | radiofrequency ablation |
RFB | rifabutin |
RFS | recurrence-free survival |
rFVIIa | recombinant activated factor VII[ |
RHC | right heart catheterization |
RhD | Rhesus D |
rhTSH | Recombinant human thyroid-stimulating hormone |
rhTSH | recombinant human thyrotropin |
RIDDLE | Radiosensitivity |
RIF | rifampin |
rK39 | recombinant K39 antigen |
RLN | recurrent laryngeal nerve |
RLQ | right lower quadrant |
RMR | Resting Metabolic Rate |
RNFL | retinal nerve fiber layer |
Ro/La | an autoantibody system |
ROR | risk of recurrence |
RP | radical prostatectomy |
RPE | Retinal pigment epithelium |
RPM | revolutions per minute |
RPR | rapid plasma reagin |
RPT | rifapentine |
rPTH | recombinant parathyroid hormone 1-34 |
RPV | rilpivirine |
RR | relative risk |
RS | recurrence score |
RS | rhinosinusitis |
RSV | Respiratory syncytial virus |
RSVVRE | vancomycin-resistant enterococcus |
RT | radiation therapy |
RT | radiotherapy |
RT | reverse transcriptase |
RT-CGM | real-time CGM[ |
rtPA | recombinant tissue plasminogen activator |
RTV | ritonavir |
RV | right ventricle |
RV | right ventricle/right ventricular |
RV | right ventricular |
RVH | right ventricular hypertrophy |
RVol | regurgitant volume |
RVOT | right ventricular outflow tract |
RVR | rapid ventricular response |
RVRTC | raised-volume rapid thoracoabdominal compression |
Rx | prescription |
Rx | therapy |
Rx | treatment |
RYGB | Roux-en-Y gastric bypass |
S | sclera |
S & Sx | signs and symptoms |
S. aureus | Staphylococcus aureus |
S. [aureus] | Staphylococcus aureus |
S/P | status post |
SA | South Asian |
SABA | short acting b2 agonist |
SABA | short-acting b-agonist References 1. Accolate(R) [package insert]. Wilmington DE: AstraZeneca LP[ |
SAD | Specific antibody deficiency |
SAE | serious adverse event |
SAH | subarachnoid hemorrhage |
SAM | Severe dermatitis |
SAMHSA | Substance Abuse and Mental Health Services Administration |
SAP | standard automated perimetry |
SAP | static threshold perimetry |
SAR | Seasonal allergic rhinitis |
SAR | specific absorption rate |
SARS | Severe Acute Respiratory Syndrome |
SAs | South Asians |
SAT | self-administered therapy |
SAVR | surgical aortic valve replacement |
SBI | Screening and Brief Intervention |
SBIRT | Screening |
SBP | systolic blood pressure |
SBRT | stereotactic body radiation therapy |
SBT | spontaneous breathing trial |
SbV | pentavalent antimony |
SC | subcutaneous |
SC | subcutaneously |
SCAI | Society for Cardiac Angiography and Interventions |
SCAR | Severe Cutaneous Adverse Reactions |
SCC | squamous cell carcinoma |
SCD | sickle cell disease |
SCD | sudden cardiac death |
SCFE | slipped capital femoral epiphysis |
SCI | spinal cord injury |
SCID | severe combined immunodeficiency |
SCIT | subcutaneous immunotherapy |
SCN | Severe congenital neutropenia |
SCr | serum creatinine |
SCT | stem-cell transplantation |
SD | stable disease |
SD-OCT | spectral domain optical coherence tomography |
SDAI | Simplified Disease Activity Index |
SDB | sleep-disordered breathing |
SDS | standard deviation score |
SE | sleep efficiency |
sec | second(s) |
SEC | secukinumab |
SERM | selective estrogen receptor modulator |
SERMs | Selective Estrogen Receptor Modulators |
SES | sirolimus-eluting stent |
SFA | seminal fluid analysis |
SFA | superficial femoral artery |
SFN | suspicious for Follicular Neoplasm |
SGA | small for gestational age |
SGD | Specific granule deficiency |
SGLT | sodium-glucose linked transporter |
SGLT-2 | sodium-glucose co-transporter 2 |
SGLT2 | sodium-glucose linked transporter-2 |
SH | Subclinical Hyperthyroidism |
SH3BP2 | SH3-domain binding protein 2 |
SHBG | sex hormone binding globulin |
SHBG | sex hormone-binding globulin |
SHD | structural heart disease (including ischemic heart disease) |
SHEA | Society for Healthcare Epidemiology of America |
SHEA | The Society for Healthcare Epidemiology of America |
SHL | sudden hearing loss |
SI | Systeme International |
SIGAD | Selective IgA deficiency |
sIgE | allergen-specific IgE |
SIGN | Scottish Intercollegiate Guideline Network |
SIHD | Stable Ischemic Heart Disease |
SIJ | sacroiliac injections |
SIR | standardized infection ratio |
SIRS | systemic inflammatory response syndrome |
SISI | Short increment sensitivity index |
SIT | saline infusion test |
SITC | Society for Immunotherapy of Cancer |
SJ | swollen joint |
SJS | Stevens-Johnson syndrome |
SKOT | Scottish Childhood Obesity Treatment Trial |
SLC46A1 | Solute carrier family 46 |
SLE | systemic lupus erythematosis |
SLE | systemic lupus erythematosus |
SLIT | sublingual immunotherapy |
SLK | Superior Limbic Keratoconjunctivitis |
SLN | sentinel lymph node |
SLN | superior laryngeal nerve |
SLN | superior laryngeal nerves |
SM | Systemic mastocytosis |
SMA | superior mesenteric artery |
SMBG | self-monitoring blood glucose |
SMD | standardized mean difference |
SMX-TMP | sulfamethoxazole-trimethoprim |
SND | Sinus Node Dysfunction |
SNFs | Skilled-nursing facilities |
SNHL | sensorineural hearing loss |
SNP | Sniff nasal pressure |
SNRI | Selective Norepinephrine Reuptake Inhibitors |
SNRI | selective serotonin-norepinephrine reuptake inhibitors |
SNRI | serotonin norepinephrine re-uptake inhibitor |
SNRI | serotonin norepinephrine reuptake inhibitor |
SNRI | serotonin-norepinephrine reuptake inhibitor |
SNRI(s) | serotonin-norepinephrine reuptake inhibitors |
SNRIs | serotonin and norepinephrine reuptake inhibitors |
SNRIs | serotonin norepinephrine reuptake inhibitors |
SOT | solid organ transplant |
SOWS | Subjective Opioid Withdrawal Scale |
SpA | spondyloarthritis |
SPAD | specific polysaccharide antibody deficiency |
SPECT | single-photon emission computerized tomography |
SPENCD | Spondyloenchondrodysplasia with immune dysregulation |
SPM | second primary malignancy |
SpO2 | saturation of peripheral oxygen |
SPP | skin perfusion pressure |
spp | species |
SPT | skin puncture test |
SQ | sequentially |
SQ | subcutaneous |
SQV | saquinavir |
SR | strong |
SR | sustained-release |
SR | systematic review |
SR | systemic reaction |
SRL | somatostatin receptor ligand |
SRLs | somatostatin receptor ligands |
SRM | small renal mass |
SRMs | small renal masses |
SRs | systemic reactions |
SRT | stereotactic radiotherapy |
SS | Site Scores |
SS | Summary Statement |
SS | summary statement: UP |
SSA | anti-Sjoegren syndrome A antibody (anti-Ro) |
SSB | anti-Sjoegren syndrome B antibody (anti-La) |
SSB | sugar-sweetened beverages |
SSBs | sugar-sweetened beverages |
SSI | sliding scale insulin |
SSI | sliding-scale [44]*insulin |
SSI | surgical site infection |
SSIs | surgical site infections |
SSNHL | sudden sensorineural hearing loss |
SSRI | selective serotonin re-uptake inhibitor |
SSRI | selective serotonin reuptake inhibitor |
SSRI | selective serotonin-reuptake inhibitors |
SSRI(s) | selective serotonin reuptake inhibitors |
SSRIs | selective serotonin reuptake inhibitors |
SST | somatostatin receptor |
SSTI | and Soft Tissue Infections |
SSTI | skin and soft tissue infection |
SSTI | skin and soft tissue infections |
SSTI | skin and soft-tissue infection |
SSTIs | and soft tissue infections |
SSZ | sulfasalazine |
STAMPEDE | Systemic Therapy in Advancing or Metastatic Prostate Cancer: Evaluation of Drug Efficacy |
StAR | steroidogenic acute regulatory protein |
STAT | Signal transducer and activator of transcription |
STC | Slow transit constipation |
STD | sexually transmitted disease |
STDs | sexually transmitted diseases |
STEC | Shiga toxin-producing E.coli |
STEMI | ST-elevation myocardial infarction |
STN | the subthalamic nucleus |
STOP-NIDDM | Study to Prevent Non-Insulin-Dependent Diabetes Mellitus |
STR | single-tablet regimen |
STS | of Thoracic Surgeons |
STS | Society of Thoracic Surgeons |
SU | sulfonylurea |
subcut | subcutaneous |
SUD | substance use disorder |
SUSP | suspicious |
SUSP | suspicious for papillary carcinoma |
Sv | Sievert |
SVC | superior vena cava |
SVG | saphenous vein graft |
SVR | sustained viral response |
SVS | for Vascular Surgery |
SVS | Society for Vascular Surgery |
SVT | supraventricular tachycardia |
Sx | symptoms |
T | testosterone |
T 1/2 | half-life |
T 1/2 | half-life |
t1/2 | half-life |
T1DM | type 1 diabetes mellitus |
T20 | enfuvirtide |
T2DM | type 2 diabetes mellitus |
T3 | triiodothyronine |
T4 | thyroid hormone |
T4 | thyroxin |
T4 | thyroxine |
TA | toxic adenoma |
TA | tricuspid annular |
TACE | transarterial chemoembolization |
TACI | Transmembrane activator and CAML interactor |
TAF | tenofovir alafenamide |
TAH | total artificial heart |
TAP | Treatment of Age-Related Macular Degeneration with Photodynamic Therapy |
TASS | Toxic anterior segment syndrome |
TAVR | transcatheter aortic valve replacement |
TB | tuberculosis |
TBG | Thyroxine binding globulin |
TBI | toe-brachial index |
TBI | traumatic brain injury |
TBK1 | TANK-binding kinase 1 |
TC | Toxigenic culture |
TC/Total-C | total cholesterol |
TCA | tricyclic antidepressant |
TCA(s) | tricyclic antidepressants |
TCAs | tricyclic antidepressants |
TCC | total contact cast |
TCD | transcranial Doppler |
TcPO | transcutaneous oxygen pressure |
TcPO2 | transcutaneous oxygen pressure |
TCR | T-cell receptor |
Td | tetanus and diphtheria toxoids (adult/ adolescent formulation) |
Td | tetanus-diphtheria |
Td | tetanus-reduced diphtheria vaccine |
Tdap | tetanus and diphtheria toxoids and acellular pertussis (adult/adolescent formulation) |
Tdap | tetanus-diphtheria-pertussis |
Tdap | tetanus-reduced diphtheria-reduced acellular pertussis vaccine |
TDD | total daily dose |
TDF | tenofovir disoproxil fumarate |
TDM | therapeutic drug monitoring |
TdP | torsades de pointes |
TEA | Total Elbow Arthroplasty |
TEE | for transesophageal echocardiography |
TEE | includes transesophageal echocardiography |
TEE | transesophageal echocardiogram |
TEE | transesophageal echocardiography |
TEN | toxic epidermal necrolysis |
TEN | toxic epidermal necrosis |
TENS | transcutaneous electrical nerve stimulation |
TEVAR | thoracic endovascular aortic repair |
TfR2 | transferrin receptor-2 |
TFTs | thyroid function tests |
Tg | thyroglobulin |
TG | triglyceride |
TG | triglycerides |
TgAb | thyroglobulin antibody |
TGN | 6-thioguanine |
THA | total hip arthroplasty |
THI | Transient hypogammaglobulinemia of infancy |
THRB | thyroid hormone receptor b |
TIA | transient ischemic attack |
TIB | time in bed |
TICAM1 | Toll-like receptor adaptor molecule 1 |
tid | 3 times a day |
tid | 3 times daily |
TID | three times a day |
tid | three times daily |
TIMI | Thrombolysis In Myocardial Infarction |
TIV | Tracheostomy invasive ventilation |
TJ | tender joint |
TKA | total knee arthroplasty |
TKI | tyrosine kinase inhibitor |
TKI | tyrosine-kinase inhibitor |
TLESR | Transient Lower Esophageal Sphincter Relaxation |
TLR | Toll-like receptor |
TM | Miniature Telescope |
TM | tympanic membrane |
TMA | transmetatarsal amputation |
tmax | time of maximum concentration |
TMC6 | transmembrane channel-like 6 |
TMEM173 | Transmembrane protein 173 |
TMEP | telangiectasia macularis eruptiva perstans |
TMNG | toxic multinodular goiter |
TMP-SMX | trimethoprim-sulfamethoxazole |
TMP-SMX | trimethoprim/sulfamethoxazole |
TMP-SMX DS | trimethoprim-sulfamethoxazole double strength (160/800 mg) |
TmP/GFR | tubular maximum for phosphate corrected for glomerular filtration rate |
TMP/SMX | trimethoprim/sulfamethoxazole |
TMR | transmyocardial revascularization |
TMS | transcranial magnetic stimulation |
TN | triple negative |
TNF | tumor necrosis factor |
TNF-a | tumor necrosis factor |
TNFi | tumor necrosis factor inhibitor |
TNFi | tumor necrosis factor-alpha inhibitors |
TNFRSF | TNF receptor superfamily |
TNFSF | TNF superfamily |
TnI | troponin I |
TnT | troponin T |
TP | toe pressure |
TPM | topiramate |
TPMT | thiopurine methyltransferase |
TPN | total parenteral nutrition |
TPO | thyroid peroxidase |
TPOAb | autoantibodies to thyroid peroxidase |
TPS | tumor proportion score |
TPV | tipranavir |
TR | tricuspid regurgitation |
TR maxPG | peak gradient of tricuspid regurgitation |
TR Vmax | tricuspid regurgitation peak velocity |
TRa | thyroid hormone receptor-a |
TRAb | thyrotropin receptor antibodies |
TRAb | thyrotropin receptor autoantibody |
TRAF3 | TNF receptor-associated factor 3 |
TRALI | transfusion-related acute lung injury |
TRAPS | TNF receptor-associated fever syndrome |
TRAPS | TNF receptor-associated periodic syndrome |
TRb | thyroid hormone receptor-b |
TREC | T-cell receptor excision circle |
Treg | Regulatory T |
TRF | Teacher Report Form |
TRH | Thyrotropin releasing hormone |
TRV | tricuspid regurgitant jet velocity |
TS | transferrin saturation |
TS | tricuspid stenosis |
TSH | thyroid stimulating hormone |
TSH | thyroid stimulating hormone. |
TSH | thyroid-stimulating hormone |
TSH | thyrotropin |
TSI | thyroid stimulation immunoglobulin |
TSS | toxic shock syndrome |
TSS | transsphenoidal selective adenomectomy |
TST | total sleep time |
TST | tuberculin skin test |
TT | thrombin time |
TT | total or near-total thyroidectomy |
TT | total testosterone |
TT4 | total T4 |
TTE | over transthoracic echocardiography |
TTE | transthoracic echocardiogram |
TTE | Transthoracic echocardiography |
TTE | transthoracic echocardiography/echocardiogram |
TTF-1 | thyroid transcription factor 1 |
TTF1 | transcription termination factor 1 |
TTO | the middle otorrhea |
TTO | tympanostomy tube otorrhea |
TTP | Thrombotic thrombocytopenic purpura |
TTX | total thyroidectomy |
TUR | transurethral resection |
TV | television |
TV | tricuspid valve |
TVR | tricuspid valve replacement |
TXNRD2 | thioredoxin reductase |
TZD | thiazolidinedione |
U | units |
UA | unstable angina |
UA/NSTEMI | unstable angina/non-ST-elevation myocardial infarction |
UACR | urine [55]*albumin-to-creatinine ratio |
UAH | unilateral adrenal hyperplasia |
uAPR | urine albumin-to-protein ratio |
UDT | urine drug testing |
UE | upper extremity |
UFC | urine free cortisol |
UFH | unfractionated heparin |
UFH | unfractionated herparin |
UGPS | Ungraded Good Practice Statement |
UGT | uridine diphosphate glucuronosyltransferase |
UICC | American Joint Committee on Cancer/Union for International Cancer Control |
UICC | Union for International Cancer Control |
UKPDS | UK Prospective Diabetes Study |
UKPDS | United Kingdom Prospective Diabetes Study |
ULN | upper limit of normal |
ULN | upper limits of normal |
ULRR | upper limit of the reference range |
ULT | urate-lowering therapy |
UP | urticaria pigmentosa |
UPLM | unprotected left main disease |
URI | upper respiratory infection |
UROD | Ultra-Rapid Opioid Detoxification |
US | ultrasonography |
US | ultrasound |
US | United States |
US ALFSG | United States Acute Liver Failure Study Group |
US CDC | United States Center for Disease Control |
USD | United States dollars |
USDA | United States Department of Agriculture |
USMSTF | U.S. Multi-Society Task Force on Colorectal Cancer |
UTI | urinary tract infection |
UV | ultraviolet |
U[alb] | urine concentration of albumin |
U[creat] | urine concentration of creatinine |
U[phos] | urine concentration of phosphorus |
U[prot] | urine concentration of protein |
U[UA] | urine concentration of uric acid |
v | velocity |
V | volts |
V/Q | ventilation-perfusion lung scan |
VAD | Ventricular Assist Device |
VAP | ventilator acquired pneumonia |
VAP | ventilator-associated pneumonia |
VAR | varicella vaccine |
VAT | ventilator-associated tracheobronchitis |
VATS | video-assisted thoracoscopic surgery |
VC | vital capacity |
VCD | vascular closure device |
VCD | vocal cord dysfunction |
VCSS | Venous Clinical Severity Scoring |
VCTE | vibration-controlled transient elastography |
VEGF | vascular endothelial growth factor |
VEGF | vascular endothelial growth factor receptor |
VF | ventricular fibrillation |
VF | vocal fold |
VHD | valvular heart disease |
VIP | Verteporfin in Photodynamic Therapy |
VISA | vancomycin-intermediate S. aureus |
VIT | venom immunotherapy |
VKA | vitamin K antagonist |
VKA | vitamin K antagonists |
VL | Visceral Leishmaniasis |
VLCFA | very long chain fatty acid |
VLU | venous leg ulcer |
VMA | vitreomacular adhesion |
Vmax | maximal velocity |
VMS | vasomotor symptoms |
VMT | vitreomacular traction |
VO2 | oxygen consumption |
VODI | Hepatic veno-occlusive disease with immunodeficiency |
Vo[2] | oxygen consumption |
VP | Permanent ventriculoperitoneal |
VP | ventriculoperitoneal |
VPA | valproate |
VQ | ventilation-perfusion |
VQI | Vascular Quality Initiative |
Vr | PSV velocity ratio (PSV at the site of a stenosis divided by the PSV in a normal vessel segment proximal to the stenosis) |
VR | range Virologic |
VRA | Visual reinforcement audiometry |
VRE | vancomycin resistant enterococci |
VRE | vancomycin-resistant enterococci |
VRE | vancomycin-resistant Enterococcus |
VRS | viral rhinosinusitis |
VS | vestibular schwannoma |
VSG | vertical sleeve gastrectomy |
VT | ventricular tachycardia |
VTE | venous thromboembolic |
VTE | venous thromboembolism |
VVA | of vulvovaginal atrophy |
VVA | vulvovaginal atrophy |
VVC | Recurrent vulvovaginal candidiasis |
VZV | varicella (herpes) zoster |
VZV | varicella zoster virus |
VZV | varicella zoster virus. |
VZV | varicella-zoster virus |
VZV | Zoster Virus |
V[max] | maximal velocity |
W | watts |
w | week(s) |
WAS | Wiskott-Aldrich syndrome |
WBC | White blood cell |
WBC | white blood cell count |
WBS | whole body scan |
WC | waist circumference |
WHI | Women's Health Initiative |
WHIM | Warts |
WHO | World Health Organization |
WIfI | Wound Ischemia and foot Infection |
wk | week |
wk | week(s) |
WPW | Wolff-Parkinson-White |
WR | weak |
WR | weight regain |
WWE | women with epilepsy |
XL | extended release. |
XLP | X-linked lymphoproliferative disease |
XOI | xanthine oxidase inhibitor |
XR | radiography |
y | year |
yr | year(s) |
ZDV | zidovudine |
ZOS | zoster vaccine. |